Hypoxia and neurodegeneration

Annals of the New York Academy of Sciences

Volumn 1177, Issue , 2009, Pages 169-177

  Peers, Chris ^a   Dallas, Mark L ^a   Boycott, Hannah E ^a   Scragg, Jason L ^a   Pearson, Hugh A ^a   Boyle, John P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Alzheimer's disease (AD); Amyloid peptide (A ); Ca2+ signaling; Calcium; Glutamate transporter; Hypoxia; Ion channels; Normoxia, dementia; Secretases amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; CELL TYPE; CONFERENCE PAPER; HOMEOSTASIS; HYPOXIA; NERVE DEGENERATION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 70350402494     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05026.x     Document Type: Conference Paper

References (48)

1. Sick, T.J., P.L. Lutz, J.C. LaManna & M. Rosenthal. 1982. Comparative brain oxygenation and mitochondrial redox activity in turtles and rats. J. Appl. Physiol. 53: 1354-1359.
2. LaManna, J.C. 2007. Hypoxia in the central nervous system. Essays Biochem. 43: 139-151.
3. Neubauer, J.A. 2001. Invited review: physiological and pathophysiological responses to intermittent hypoxia. J. Appl. Physiol. 90: 1593-1599.
4. Peers, C., H.A. Pearson & J.P. Boyle. 2007. Hypoxia and Alzheimer's disease. Essays Biochem. 43: 153-164.
5. Bradley, T.D. & J.S. Floras. 2009. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373: 82-93.
6. Skoog, I. & D. Gustafson. 2006. Update on hypertension and Alzheimer's disease. Neurol. Res. 28: 605-611.
7. Sparks, D.L., T.A. Martin, D.R. Gross & J.C. Hunsaker, III. 2000. Link between heart disease, cholesterol, and Alzheimer's disease: A review. Microsc. Res. Tech. 50: 287-290.
8. Gustafson, D., E. Rothenberg, K. Blennow, et al. 2003. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch. Intern. Med. 163: 1524-1528.
9. Kalmijn, S., D. Foley, L. White, et al. 2000. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler. Thromb. Vasc. Biol. 20: 2255-2260.
10. de la Torre, J.C. 2000. Critically attained threshold of cerebral hypoperfusion: the CATCHhypothesis of Alzheimer's pathogenesis. Neurobiol. Aging 21: 331-342.
11. Kalback, W., C. Esh, E.M. Castano, et al. 2004. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol. Res. 26: 525-539.
12. Incalzi, R.A., A. Gemma, C. Marra, et al. 1993. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am. Rev. Respir. Dis. 148: 418-424.
13. Kokmen, E., J.P. Whisnant, W.M. O'Fallon, et al. 1996. Dementia after ischemic stroke: A populationbased study in Rochester, Minnesota (1960-1984). Neurology 46: 154-159.
14. Moroney, J.T., E. Bagiella, D.W. Desmond, et al. 1997. Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke. Ann. N. Y. Acad. Sci. 826: 433-436.
15. Tatemichi, T.K., M. Paik, E. Bagiella, et al. 1994. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44: 1885-1891.
16. Desmond, D.W., J.T. Moroney, M. Sano & Y. Stern. 2002. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33: 2254-2260.
17. Desmond, D.W., J.T. Moroney, M. Sano & Y. Stern. 2002. Mortality in patients with dementia after ischemic stroke. Neurology 59: 537-543.
18. Hornbein, T.F. 1992. Long term effects of high altitude on brain function. Int. J. Sports Med. 13 (Suppl 1): S43-S45.
19. Nelson, T.O., J. Dunlosky, D.M. White, et al. 1990. Cognition andmetacognition at extreme altitudes on Mount Everest. J. Exp. Psychol. Gen. 119: 367-374.
20. Chleide, E., J. Bruhwyler & M. Mercier. 1991. Effect of chronic hypoxic treatment on the retention of fixed-interval responding. Physiol. Behav. 49: 465-470.
21. Ferri, C.P., M. Prince, C. Brayne, et al. 2005. Global prevalence of dementia: A Delphi consensus study. Lancet 366: 2112-2117.
22. Mudher, A. & S. Lovestone. 2002. Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci. 25: 22-26.
23. Hardy, J.A. & G.A. Higgins. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
24. Vardy, E.R., A.J. Catto &N.M.Hooper. 2005. Proteolyticmechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease. Trends Mol. Med. 11: 464-472.
25. Selkoe, D.J. & M.S. Wolfe. 2007. Presenilin: running with scissors in the membrane. Cell 131: 215-221.
26. Green, K.N. & F.M. LaFerla. 2008. Linking calcium to Abeta and Alzheimer's disease. Neuron 59: 190-194.
27. Arispe,N., E.Rojas&H.B. Pollard. 1993. Alzheimerdisease amyloid beta-protein forms calcium channels in bilayer-membranes-blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90: 567-571.
28. Dreses-Werringloer, U., J.C. Lambert, V. Vingtdeux, et al. 2008. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 133: 1149-1161.
29. Reddy, P.H. 2006. Amyloid precursor proteinmediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 96: 1-13.
30. Taylor, S.C., T.F. Batten & C. Peers. 1999. Hypoxic enhancement of quantal catecholamine secretion. Evidence for the involvement of amyloid betapeptides. J. Biol. Chem. 274: 31217-31222.
31. Green, K.N.&C. Peers. 2001.Amyloid beta peptides mediate hypoxic augmentation of Ca2+ channels. J. Neurochem. 77: 953-956.
32. Webster, N.J., M. Ramsden, J.P. Boyle, et al. 2006. Amyloid peptidesmediate hypoxic increase of L-type Ca2+ channels in central neurones. Neurobiol. Aging 27: 439-445.
33. Scragg, J.L., I.M. Fearon, J.P. Boyle, et al. 2005. Alzheimer's amyloid peptides mediate hypoxic upregulation of L-type Ca2+ channels. FASEB J 19: 150-152.
34. Brown, S.T., J.L. Scragg, J.P. Boyle, et al. 2005. Hypoxic augmentation of Ca2+ channel currents requires a functional electron transport chain. J. Biol. Chem. 280: 21706-21712.
35. Peers, C., I.F. Smith, J.P. Boyle &H.A. Pearson. 2004. Remodelling of Ca2+ homeostasis in type I cortical astrocytes by hypoxia: evidence for association with Alzheimer's disease. Biol. Chem. 385: 285-289.
36. Smith, I.F., J.P. Boyle, K.N. Green, et al. 2004. Hypoxic remodeling of Ca2+ mobilization in type I cortical astrocytes: involvement of ROS and proamyloidogenic APP processing. J. Neurochem. 88: 869-877.
37. Peers, C., I. Johnston, B. Lang & D. Wray. 1993. Cross-linking of presynaptic calcium channels-a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscularjunction. Neurosci. Lett. 153: 45-48.
38. Smith, I.F., J.P. Boyle, P.F. Vaughan, et al. 2001. Effects of chronic hypoxia on Ca2+ stores and capacitative Ca2+ entry in human neuroblastoma (SH-SY5Y) cells. J. Neurochem. 79: 877-884.
39. Smith, I.F., L.D. Plant, J.P. Boyle, et al. 2003. Chronic hypoxia potentiates capacitative Ca2+ entry in type I cortical astrocytes. J. Neurochem. 85: 1109-1116.
40. Smith, I.F., J.P. Boyle, L.D. Plant, et al. 2003. Hypoxic remodeling ofCa2+ stores in type I cortical astrocytes. J. Biol. Chem. 278: 4875-4881.
41. Atkinson, L., J.P. Boyle, H.A. Pearson & C. Peers. 2006. Chronic hypoxia inhibits Na+/Ca2+ exchanger expression in cortical astrocytes. Neuroreport 17: 649-652.
42. Dallas, M.L., H.E. Boycott, L. Atkinson, et al. 2007. Hypoxia suppresses glutamate transport in astrocytes. J. Neurosci. 27: 3946-3955.
43. Dallas, M., J.L. Scragg & C. Peers. 2008. Modulation of hTREK-1 by carbon monoxide. Neuroreport 19: 345-348.
44. Boycott, H.E., J.A. Wilkinson, J.P. Boyle, et al. 2008. Differential involvement of TNF alpha in hypoxic suppression of astrocyte glutamate transporters. Glia 56: 998-1004.
45. Boycott, H.E., M. Dallas, J.P. Boyle, et al. 2007. Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation. Biochem. Biophys. Res. Commun. 364: 100-104.
46. Webster, N.J., K.N. Green, C. Peers & P.F. Vaughan. 2002. Altered processing of amyloid precursor protein in the human neuroblastoma SHSY5Y by chronic hypoxia. J. Neurochem. 83: 1262-1271.
47. Guglielmotto,M., M. Aragno, R. Autelli, et al. 2009. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J. Neurochem. 108: 1045-1056.
48. Fisk, L., N.N. Nalivaeva, J.P. Boyle, et al. 2007. Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res. 32: 1741-1748.